Sunshine Biopharma Inc.
SBFM | NASDAQ
$0.92
+$0.01 (+1.20%)
Sep 22, 2026, 10:30 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9.26M | 8.09M | 8.58M | 9.42M | 9.41M | 8.9M | 9.59M | 8.44M | 9.3M | 7.54M | 7.68M | 5.96M | 5.56M | 4.89M | 3.94M | 132.81K | 150.31K | 122.65K | 85.12K | 50.38K | 52.87K | 40.06K |
Cost of Revenue | 6.84M | 5.98M | 5.65M | 6.34M | 5.99M | 6.17M | 6.5M | 5.57M | 6.95M | 5.19M | 5.11M | 3.97M | 3.61M | 3.07M | 2.45M | 65.78K | 74.68K | 59.85K | 61.29K | 19.51K | 18.52K | 18.52K |
Gross Profit | 2.43M | 2.1M | 2.93M | 3.07M | 3.42M | 2.73M | 3.09M | 2.87M | 2.36M | 2.35M | 2.57M | 1.99M | 1.95M | 1.83M | 1.49M | 67.03K | 75.62K | 62.8K | 23.83K | 30.87K | 34.36K | 21.54K |
Operating Income | -1.61M | -1.4M | -1.66M | -531.96K | -992.85K | -1.3M | -2.04M | -1.11M | -1.27M | -1.35M | -1.19M | -779.47K | -1.01M | -1.83M | -23.36M | -1.72M | -695.8K | -1.22M | -279.63K | -496.26K | -388.6K | -1.28M |
Interest Income | 48.82K | 48.43K | 57.47K | 75.35K | 72.72K | 75.37K | 99.31K | 108.61K | 144K | 144.09K | 187.61K | 207.43K | 203.05K | 213.88K | 111.67K | 260.94K | 146.04K | 3 | n/a | n/a | 2 | n/a |
Pretax Income | -1.56M | -1.24M | -1.73M | -1.02M | -1.98M | -1.22M | -2.29M | -982.59K | -837.99K | -1.26M | -1.03M | -610.53K | -814.43K | -1.66M | -23.28M | -1.46M | -538.87K | -1.24M | 667.12K | -4.04M | -2.88M | -6.19M |
Net Income | -1.56M | -1.24M | -2.14M | -883.82K | -1.77M | -1.18M | -2.16M | -1.2M | -494.3K | -1.28M | -1.25M | -651.48K | -902.11K | -1.7M | -23.51M | -1.46M | -538.87K | -1.24M | 667.12K | -4.04M | -2.88M | -6.19M |
Selling & General & Admin | 3.95M | 3.34M | 8.69M | 3.27M | 4.03M | 3.64M | 4.81M | 3.73M | 2.99M | 3.36M | 2.82M | 2.44M | 2.47M | 3.13M | 6.41M | 1.42M | 723.19K | 921.4K | 209.08K | 301.48K | 228.01K | 1.13M |
Research & Development | 13.22K | 31.72K | -530.81K | 119.3K | 196.23K | 215.28K | 149.27K | 126.36K | 436.24K | 222.03K | 816.33K | 238.01K | 368.57K | 432.93K | 41.76K | 362.5K | 45.94K | 361.65K | 91.2K | 222.47K | 191.76K | 166.79K |
Other Expenses | 77.97K | 129.66K | -3.57M | 215.73K | 185.21K | 174.97K | 174.24K | 121.1K | 196.67K | 118.52K | 119.13K | 89.8K | 131.53K | 98.43K | 18.4M | 789 | 2.29K | 3.11K | 3.18K | 3.18K | 3.19K | 3.18K |
Operating Expenses | 4.04M | 3.5M | 4.59M | 3.61M | 4.42M | 4.03M | 5.13M | 3.97M | 3.62M | 3.7M | 3.76M | 2.77M | 2.97M | 3.66M | 24.85M | 1.79M | 771.42K | 1.29M | 303.46K | 527.13K | 422.96K | 1.3M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 8.53K | n/a | 245 | 49.18K | 30.11K | 38.53K | 3.33K | 41.08K | 26.55K | n/a | n/a | 12.86K | 36.63K | 46.85K | 195.63K | 49.71K |
Selling & Marketing Expenses | 209.34K | n/a | 308.69K | 235.22K | 201.66K | 398.36K | 203.16K | 282.75K | 256.33K | 198.05K | 231.26K | 241.9K | 133.18K | 127.91K | 177.7K | 217.67K | 87.68K | 95.04K | 41.38K | 130K | 22K | 1.02M |
Cost & Expenses | 10.88M | 9.48M | 10.24M | 9.95M | 10.4M | 10.2M | 11.63M | 9.54M | 10.57M | 8.89M | 8.87M | 6.74M | 6.57M | 6.72M | 27.3M | 1.85M | 846.1K | 1.35M | 364.75K | 546.64K | 441.47K | 1.32M |
Income Tax Expense | n/a | n/a | 408.37K | -137.44K | -209.17K | -40.16K | -128.74K | 215.22K | -343.69K | 22.35K | 220.27K | 40.95K | 87.68K | 46.27K | 233.3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.37M | 490.6K | 415.71K | 465.17K | 22.48K | 270.3K | 258K | 126.8K | 4.97K | 3.21K | 1.19K | 1.29K | 126.8K | 1.1K | 2.24M | 18.89K | 792 | 527.29K | 358.5K | 254.3K | 239.3K | 219.4K |
Shares Outstanding (Diluted) | 1.37M | 490.6K | 415.71K | 465.17K | 22.48K | 270.3K | 258K | 126.8K | 4.97K | 3.21K | 1.19K | 1.29K | 126.8K | 1.1K | 2.26M | 18.89K | 792 | 527.29K | 358.5K | 254.3K | 239.3K | 219.4K |
EPS (Basic) | -1.15 | -2.50 | -4.60 | -1.90 | -78 | -4.40 | -8.40 | -9.40 | -99.40 | -400.40 | -1.05K | -507.20 | -7.10 | -1.55K | -10.50 | -1.6K | -600 | -4.6K | 6.50 | -31.8K | -24.2K | -56.4K |
EPS (Diluted) | -1.15 | -2.50 | -4.60 | -1.90 | -78 | -4.40 | -8.40 | -9.40 | -99.40 | -400.40 | -1.05K | -507.20 | -7.10 | -1.55K | -10.40 | -1.6K | -600 | -4.69K | 6.50 | -31.8K | -24.2K | -56.4K |
EBITDA | -1.53M | -1.17M | -1.63M | -925.1K | -1.91M | -1.16M | -2.21M | -917.95K | -786.87K | -1.17M | -957.29K | -534.79K | -776.22K | -1.58M | -23.23M | -1.46M | -536.59K | -1.22M | 706.93K | -3.99M | -2.68M | -6.13M |
EBIT | -1.61M | -1.24M | -1.73M | -1.02M | -1.98M | -1.22M | -2.28M | -982.59K | -837.75K | -1.21M | -999.65K | -572K | -811.1K | -1.62M | -23.25M | -1.46M | -538.87K | -1.22M | 703.75K | -3.99M | -2.68M | -6.14M |
Depreciation & Amortization | 77.97K | 76.86K | 98.58K | 96.16K | 72.53K | 64.79K | 65.41K | 64.63K | 50.88K | 42.62K | 42.35K | 37.2K | 34.88K | 34.71K | 18.98K | 789 | 2.29K | 3.11K | 3.18K | 3.18K | 3.19K | 3.18K |
Add to Watchlist
Select watchlists to add or remove SBFM